LEO 27847 - Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study in Secondary Hyperparathyroidism Patients

Clinical trial NCT01167309 · COMPLETED

Trial details

NCT number: NCT01167309
Sponsor: LEO Pharma
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Secondary Hyperparathyroidism

Start date: 2010-06-01
Primary completion: 2011-10-01
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.